188 related articles for article (PubMed ID: 38504100)
1. NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection.
Zhao Y; Ma C; Cai R; Xin L; Li Y; Ke L; Ye W; Ouyang T; Liang J; Wu R; Lin Y
Nat Commun; 2024 Mar; 15(1):2463. PubMed ID: 38504100
[TBL] [Abstract][Full Text] [Related]
2. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
3. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma.
Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889
[TBL] [Abstract][Full Text] [Related]
4. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.
Zhu Q; Huang L; Yang Q; Ao Z; Yang R; Krzesniak J; Lou D; Hu L; Dai X; Guo F; Liu F
Nanoscale; 2021 Oct; 13(39):16457-16464. PubMed ID: 34648610
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
7. Raman spectroscopy and machine learning for the classification of esophageal squamous carcinoma.
Huang W; Shang Q; Xiao X; Zhang H; Gu Y; Yang L; Shi G; Yang Y; Hu Y; Yuan Y; Ji A; Chen L
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121654. PubMed ID: 35878494
[TBL] [Abstract][Full Text] [Related]
8. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
10. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.
Liu L; Wu J; Shi M; Wang F; Lu H; Liu J; Chen W; Yu G; Liu D; Yang J; Luo Q; Ni Y; Jin X; Jin X; Chen WL
Genomics Proteomics Bioinformatics; 2022 Aug; 20(4):670-687. PubMed ID: 35351627
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
12. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
13. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice.
Ma W; Ma L; Zhe H; Bao C; Wang N; Yang S; Wang K; Cao F; Cheng Y; Cheng Y
PLoS One; 2014; 9(3):e92351. PubMed ID: 24618814
[TBL] [Abstract][Full Text] [Related]
14. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
15. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
16. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
17. 1H-NMR based metabonomic profiling of human esophageal cancer tissue.
Wang L; Chen J; Chen L; Deng P; Bu Q; Xiang P; Li M; Lu W; Xu Y; Lin H; Wu T; Wang H; Hu J; Shao X; Cen X; Zhao YL
Mol Cancer; 2013 Apr; 12():25. PubMed ID: 23556477
[TBL] [Abstract][Full Text] [Related]
18.
Ouyang T; Ma C; Zhao Y; Ye W; Zhao J; Cai R; Zhang H; Zheng P; Lin Y
Front Oncol; 2023; 13():1082841. PubMed ID: 36756157
[TBL] [Abstract][Full Text] [Related]
19. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
